Early detection of colorectal cancer

Oncodrex has developed a simple blood-based test for the screening and early detection of precancerous and cancerous lesions of colon and rectum.

Colorectal cancer (CRC) is one of the most preventable cancers with screening and yet still is the third leading cause of cancer death worldwide. Given the high impact of CRC, there is an urgent need for a convenient, accurate and cost-effective screening test that could triage patients for more intensive procedures such as colonoscopy. This would improve patient compliance and clinical outcomes with resulting significant impact on both population health and health care costs. A blood-based screening test is an attractive alternative to increase compliance. Additionally, if an improved screening test could also detect pre-malignant polyps, this would provide an extraordinary opportunity not only to identify early, but also to actually prevent cancer since patients with positive screening tests for pre-malignant lesions can be followed up with colonoscopy to remove these lesions before developing cancer.